Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
3SBio ( (HK:1530) ) has provided an update.
3SBio Inc. announced a final ordinary cash dividend of HKD 0.25 per share for the financial year ending December 31, 2024. This announcement, made on March 25, 2025, indicates a stable financial performance and commitment to shareholder returns, with the payment scheduled for August 15, 2025. The dividend reflects the company’s ongoing efforts to enhance shareholder value and its strong position in the biopharmaceutical market.
More about 3SBio
3SBio Inc. operates in the biotechnology industry, focusing on the development, manufacturing, and marketing of biopharmaceutical products. The company is known for its innovative treatments and has a significant market presence in the healthcare sector.
YTD Price Performance: 25.97%
Technical Sentiment Signal: Sell
Current Market Cap: $3.28B
See more insights into 1530 stock on TipRanks’ Stock Analysis page.